Skip to main content
LIWANLI logo

LIWANLI — Investor Relations & Filings

Ticker · 3054 ISIN · TW0003054003 TW Wholesale and retail trade
Open in API
Filings indexed 1,630 across all filing types
Latest filing 2024-11-20 Share Issue/Capital Cha…
Country TW Taiwan
Listing TW 3054

About LIWANLI

https://www.liwanli.com.tw

Liwanli Innovation Co., Ltd. is a technology-driven enterprise that transitioned from its origins in mobile multimedia and storage solutions into the biotechnology and healthcare sectors. Originally established in 1991, the company underwent a strategic rebranding in 2015 to focus on the research, development, and distribution of health supplements and nutritional products. Its core operations involve the creation of patented formulas and the application of innovative R&D techniques to meet consumer wellness needs. The company leverages extensive industry-university collaborations and maintains advanced laboratory facilities to ensure the scientific integrity of its product offerings. In addition to its primary focus on biotechnology and health products, the company continues to engage in the sale of electronic components and consumer electronics, emphasizing a philosophy of precision and nutritional excellence.

Recent filings

Filing Released Lang Actions
113年11月變更登記
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about the company's capital structure, including authorized capital, paid-in capital, share capital changes, and specific notes about capital reduction and treasury stock cancellation. It does not present a full financial report or earnings data but rather focuses on capital changes and share capital details. The document length is short (803 characters), and it is a direct disclosure of capital information rather than an announcement of a report. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues, stock splits, or other capital changes.
2024-11-20 Chinese
113年第3季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for a specific period (the third quarter of the 113th year, presumably a fiscal quarter). The content is tabular and concise, focusing on investment details rather than a full financial report. The document length is only 646 characters, which is very short and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure or announcement of investment information rather than a full report like an Annual Report (10-K) or Interim Report (IR). Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-11-11 Chinese
113年第3季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by a Taiwanese listed company. It includes specific financial figures, investment methods, and regulatory limits, but it is not a full financial report or earnings release. The document length is short (1295 characters), and it does not appear to be an announcement of a report publication or a certification. It is a regulatory disclosure of investment information, likely required by a regulatory body for transparency purposes. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-11-11 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, providing information about the absence of fund loans and endorsement guarantees for the current and previous months, with amounts stated as zero. It contains no detailed financial statements, no management discussion, no voting results, no legal proceedings, and no mention of report attachments or certifications. The content is regulatory in nature, reporting compliance-related financial data but not constituting a full report or announcement of a report. Given the short length (602 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-11-07 Chinese
113年10月營業收入
Regulatory Filings Classification · 90% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company, including percentage changes and explanatory notes. It is very short (777 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a regulatory or public disclosure of revenue figures rather than a full financial report. There is no indication that this is an earnings release or an interim report with substantive financial data. Given the short length and nature of the content, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2024-11-07 Chinese
113年10月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders such as directors, general managers, and other key personnel. It includes specific data on shares held, increases, decreases, and trust shares. The content focuses on insider share transactions and holdings rather than financial results, management changes, or regulatory announcements. There is no indication of it being a full financial report, earnings release, or management discussion. The document is not a brief announcement but a detailed insider shareholding report. Therefore, it fits the category of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length (9218 characters) supports it being a substantive report rather than a brief announcement.
2024-11-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.